Multimodal clinical parameters-based immune status associated with the prognosis in patients with hepatocellular carcinoma

Figure 3 Future prospects of study design and statistic method for prognostic prediction of hepatocellular carcinoma patients based on analysis of multimodal clinical parameters. Based on the multimodal clinical parameters, follow-up studies will center on four key areas: Observation studies, clinical trials, prognosis analyses, and clinical decision tools. Diverse statistical methods, covering linear and nonlinear models as well as machine learning and deep learning models, can be applied for achieving comprehensive and in-depth research results.